Bill Detail
H.R. 3160
Congress: 119
Title
PREVAIL Act
Summary
Promoting and Respecting Economically Vital American Innovation Leadership Act or the PREVAIL Act This bill addresses various issues relating to the U.S. Patent and Trademark Office (USPTO), including by imposing additional requirements on administrative patent validity challenges (proceedings to review and potentially cancel issued patents) at the USPTO. The bill modifies provisions relating to inter partes reviews (IPRs) and other administrative patent validity proceedings, including by prohibiting an administrative patent judge who participated in deciding whether to institute an IPR (i.e., whether to allow the IPR to proceed based on the initial petition) from also participating in deciding the final outcome of the same IPR; prohibiting a person (individual or entity) from petitioning for an IPR against a patent unless the person meets certain standing requirements (currently, any person may petition for an IPR); prohibiting a person who has challenged a patent's validity in an IPR from raising the same challenges against the patent in other proceedings (e.g., district court) if the IPR has been instituted; and raising the burden that the petitioner in an IPR must meet to invalidate a previously issued patent claim. The bill also makes institutions of higher education (IHEs) and nonprofit entities that hold patents on behalf of IHEs eligible for reduced patent-related fees, including filing fees. (Currently, employees of IHEs are eligible for reduced fees but not the IHEs themselves.) The bill also makes fees collected by the USPTO available for the USPTO's use without further appropriations from Congress.
Sponsor
Rep. Nathaniel Moran [R-TX-1]
Status
Referred to the House Committee on the Judiciary.
Status as of Jun 29, 12:18 PM · synced 8h ago
Introduced
2025-05-01
Data source mode: cache
Bill Engagement
Promoting and Respecting Economically Vital American Innovation Leadership Act or the PREVAIL Act This bill addresses various issues relating to the U.S. Patent and Trademark Of…
Lobbyists on the case
- Pharmaceutical Research and Manufacturers of America4 filings · 17 lobs
- Biotechnology Innovation Organization3 filings · 7 lobs
- Akin Gump Strauss Hauer & Feld2 filings · 4 lobs
- Amazon.com Services LLC1 filing · 9 lobs
- Covington & Burling LLP1 filing · 5 lobs
- Acg Advocacy1 filing · 3 lobs
- Bart Forsyth2026 Q1
- Lauren Jee2026 Q1
- David Korn2026 Q1
- John Nappi2026 Q1
- Maria Olson2026 Q1Pharmaceutical Research and Manufacturers of America · Leg.Asst., Prof.Staff - Sen. Susan Collins; Prof.Staff - Senate HELP …
- Lori Reilly2026 Q1
- Zach Sentementes2026 Q1
- Steve Tilton2026 Q1